By December 2030, implement and evaluate in up to 90 IBD care sites the key components of the IBD Learning Health System that enables continuous collection of health information to improve quality of care in IBD.
To compare the effectiveness of two approaches for the management of Barrett’s esophagus (BE) and low-grade dysplasia (LGD), endoscopic surveillance and endoscopic eradication therapy (EET), using an accepted clinical endpoint of neoplastic progression [high-grade dysplasia (HGD)/mucosal esophageal adenocarcinoma (EAC)/invasive EAC].